Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleftherios Mylonakis

Showing results (121-130 of 451) with videos related to

Pageof 46
Sort By:
Plos One|February 1, 2017
Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-AnalysisMyrto Eleni Flokas, Styliani Karanika, Michail Alevizakos, et al.
Expert Opinion on Drug Discovery|April 13, 2017
An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugsWooseong Kim, Gabriel Lambert Hendricks, Kiho Lee, et al.
Frontiers in Microbiology|August 6, 2019
The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant <i>Staphylococcus aureus</i>Nagendran Tharmalingam, Rajamohammed Khader, Beth Burgwyn Fuchs, et al.
The Journal of Infection|August 1, 2016
Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysisMyrto Eleni Flokas, Marios Detsis, Michail Alevizakos, et al.
Plos One|October 4, 2011
Antifungal activity of microbial secondary metabolitesJeffrey J Coleman, Suman Ghosh, Ikechukwu Okoli, et al.
Frontiers in Pharmacology|February 23, 2023
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort studyYazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, et al.
Expert Opinion on Drug Discovery|June 21, 2011
Using C. elegans for antimicrobial drug discoveryAthanasios Desalermos, Maged Muhammed, Justin Glavis-Bloom, et al.
International Journal of Antimicrobial Agents|April 16, 2018
The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysisNikolaos Andreatos, Fadi Shehadeh, Elina Eleftheria Pliakos, et al.
Expert Opinion on Pharmacotherapy|February 4, 2021
Current and promising pharmacotherapeutic options for candidiasisLiliana Scorzoni, Beth Burgwyn Fuchs, Juliana Campos Junqueira, et al.
Plos Currents|June 12, 2015
Modeling the 2014 Ebola Virus Epidemic - Agent-Based Simulations, Temporal Analysis and Future Predictions for Liberia and Sierra LeoneConstantinos Siettos, Cleo Anastassopoulou, Lucia Russo, et al.
Pageof 46

Showing results (121-130 of 451) with videos related to

Sort By:
Pageof 46
Plos One|February 1, 2017
Prevalence of ESBL-Producing Enterobacteriaceae in Pediatric Bloodstream Infections: A Systematic Review and Meta-AnalysisMyrto Eleni Flokas, Styliani Karanika, Michail Alevizakos, et al.
Expert Opinion on Drug Discovery|April 13, 2017
An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugsWooseong Kim, Gabriel Lambert Hendricks, Kiho Lee, et al.
Frontiers in Microbiology|August 6, 2019
The Anti-virulence Efficacy of 4-(1,3-Dimethyl-2,3-Dihydro-1H-Benzimidazol-2-yl)Phenol Against Methicillin-Resistant <i>Staphylococcus aureus</i>Nagendran Tharmalingam, Rajamohammed Khader, Beth Burgwyn Fuchs, et al.
The Journal of Infection|August 1, 2016
Prevalence of ESBL-producing Enterobacteriaceae in paediatric urinary tract infections: A systematic review and meta-analysisMyrto Eleni Flokas, Marios Detsis, Michail Alevizakos, et al.
Plos One|October 4, 2011
Antifungal activity of microbial secondary metabolitesJeffrey J Coleman, Suman Ghosh, Ikechukwu Okoli, et al.
Frontiers in Pharmacology|February 23, 2023
Incidence and potential risk factors for remdesivir-associated bradycardia in hospitalized patients with COVID-19: A retrospective cohort studyYazed Saleh Alsowaida, Fadi Shehadeh, Markos Kalligeros, et al.
Expert Opinion on Drug Discovery|June 21, 2011
Using C. elegans for antimicrobial drug discoveryAthanasios Desalermos, Maged Muhammed, Justin Glavis-Bloom, et al.
International Journal of Antimicrobial Agents|April 16, 2018
The impact of antibiotic prescription rates on the incidence of MRSA bloodstream infections: A county-level, US-wide analysisNikolaos Andreatos, Fadi Shehadeh, Elina Eleftheria Pliakos, et al.
Expert Opinion on Pharmacotherapy|February 4, 2021
Current and promising pharmacotherapeutic options for candidiasisLiliana Scorzoni, Beth Burgwyn Fuchs, Juliana Campos Junqueira, et al.
Plos Currents|June 12, 2015
Modeling the 2014 Ebola Virus Epidemic - Agent-Based Simulations, Temporal Analysis and Future Predictions for Liberia and Sierra LeoneConstantinos Siettos, Cleo Anastassopoulou, Lucia Russo, et al.
Pageof 46